# Genetics and Genomics

1. Pharmacogenomics
      * "List the most common pharmacogenomic biomarkers for drug metabolism analysis, and what the most common genotypes indicate."
2. Genetic Mutation Impacts
      * "What are the effects of the F508del mutation in the CFTR gene on cystic fibrosis patients?"
3. Genome/Epigenome Editing Techniques
      * "Describe how CRISPR-Cas9 technology can be used to correct genetic mutations in human cells."
      * "Describe the methodologies and potential therapeutic applications of targeted epigenome editing using dCas9 fusion proteins."
4. Functional Genomics Applications
      * "Discuss the use of CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) for functional genomic screens to identify gene regulatory networks."

5. Interpreting Complex Genomic Variants
      * "Explain how structural variants like copy number variations contribute to genetic disorders, and discuss methods for their detection using next-generation sequencing data."

6. Population Genomics and Evolution
      * "Analyze how genome-wide association studies (GWAS) can be used to understand the genetic basis of complex traits and diseases in diverse populations."

7. Mitochondrial Genetics
      * "Discuss the challenges and techniques involved in studying mitochondrial DNA mutations and their implications for metabolic diseases."

8. Translational Genomics
      * "Explain how advances in genomics have led to personalized medicine approaches in oncology, including the use of genomic biomarkers for targeted therapies."

9. Non-Coding RNAs in Regulation
      * "Discuss the roles of long non-coding RNAs (lncRNAs) in gene regulation and their potential as therapeutic targets."

10. Horizontal Gene Transfer in Humans
      * "Evaluate the evidence and implications of horizontal gene transfer events in the human genome."

11. Comparative Genomics
      * "Explain how comparative genomics between humans and model organisms can aid in the identification of conserved regulatory elements."

12. Ethical Considerations in Genomics
      * "Discuss the ethical, legal, and social implications (ELSI) of whole-genome sequencing in newborn screening programs."
